Vinings Holdings Inc. Share Price Other OTC
Equities
NDYN
US92744A1051
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 26.74M 2.1B |
---|---|---|---|---|---|
Net income 2022 | -37M -2.91B | Net income 2023 | -21M -1.65B | EV / Sales 2022 | - |
Net cash position 2022 | 2.08M 164M | Net cash position 2023 | 245K 19.25M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.58
x | P/E ratio 2023 |
-0.95
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.36% |
Managers | Title | Age | Since |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 27/10/22 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 16/05/23 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 27/10/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 27/10/22 | |
Director/Board Member | 55 | 27/10/22 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 27/10/22 |
1st Jan change | Capi. | |
---|---|---|
+37.93% | 723B | |
+34.36% | 595B | |
-2.78% | 369B | |
+20.57% | 332B | |
+2.39% | 282B | |
+17.26% | 244B | |
+9.60% | 208B | |
-4.58% | 205B | |
+0.16% | 168B |